# Kedrion Biopharma Inc. – FDA Inspection, Aug 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/65d6df47-9734-470a-9896-5df11ddf3333
Source feed: FDA_Inspections

> FDA inspection 1064655 of Kedrion Biopharma Inc., August 29, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1064655
- Company Name: Kedrion Biopharma Inc.
- Inspection Date: 2018-08-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1231467 - 2024-03-27
- FDA Inspection 1148187 - 2021-06-25
- [FDA Inspection 1079026 - 2018-11-16](https://www.keypedia.com/records/fda_inspections/kedrion-biopharma-inc/b8e2cc2d-0f5f-43fb-9760-367882106354)
- FDA Inspection 900509 - 2014-09-29
- FDA Inspection 801013 - 2012-08-02

## Related Officers

- [Company Rep](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- Issuing Officer

Company: https://www.keypedia.com/companies/kedrion-biopharma-inc/e6cf606f-c996-4278-ad90-ec69fbd2a7f7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
